References
- 1. WilckenDEL The pathogenesis of coronary artery disease. A possible role fo methionine metabolism. J Clin Invest, 1976; 57: 1079–8210.1172/JCI108350436752947949
- 2. Wald D, Law M, Morris J. Homocysteine and cardiovascular disease: evidence on causality from a meta–analysis. BMJ 2002; 325: 120210.1136/bmj.325.7374.120213549112446535
- 3. Whincup PH, Refsum H, Perry IJ, Morris R, Walker M, L. Lennon, Thomson A, Ueland PM, Ebrahim BJ. Serum total homocystein and coronary heart disease: prospective study in middle aged men. Heart 1999; 82: 448–45410.1136/hrt.82.4.448176028310490559
- 4. Ridker PM, Shih J, Cook TJ, ClearfieldM, Downs JR, Pradhan AD, Weiss SE, Gotto AM. Plasma homocystein concentration, statin therapy and risk of first acute coronary events. Circulation. 2002; 1055): 1776–910.1161/01.CIR.0000014447.06099.FB
- 5. Stubbs PJ et al. Effect of plasma homocysteine on early and late events in patients with acute coronary syndromes. Circulation,2000; 102: 605–1010.1161/01.CIR.102.6.605
- 6. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter–Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007 Jan; 45 Suppl S: S5–6710.1016/j.jvs.2006.12.03717223489
- 7. Ganguly P, Alam Fatima S. Role of homocysteine in the development of cardiovascular disease.Nutrition journal 2015; 14: 610.1186/1475-2891-14-6432647925577237
- 8. Ghosh Sh, Sanchita R, Soumitra K, Pritha P, Atreyee D, Ajantal H. Homocysteine–Is there any role in coronary artery disease? J. Cardiocascular disease research., 2017; 8(2): 46–4910.5530/jcdr.2017.2.11
- 9. Malinow MR et al. Homocysteine, diet and cardiovascular disease. A statement for health professionals from Nutrition Committee, American Heart Association. Circulation,1999; 99: 178–8210.1161/01.CIR.99.1.178
- 10. Soinio M, Marniemi J, Laakso S, RonnemaaT. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes. Ann Intern Med 2004; 140: 94–10010.7326/0003-4819-140-2-200401200-0000914734331
- 11. Ranjith R, Devika P. Clinical correlation between plasma homocysteine level and coronary artery disease in Indian patients. World journal of Cardiovascular disease 2017; 7: 477–48510.4236/wjcd.2017.712047
- 12. J.A. TroughtonJ.V. Woodside I.S. Young D. Arveiler P. AmouyelJ. FerrièresP. DucimetièreC.C. PattersonF. KeeJ.W.G. YarnellA. Evans on behalf of the PRIME Study Group: Homocysteine and coronary heart disease risk in the PRIME study
- 13. Yang X, Zhou Y, Liu C, Gao X, Wang A, Guo Y, et al. Homocysteine and carotid plaque stability: a cross–sectional study in Chinese adults. PLOS ONE 2014; 9(4): e9493510.1371/journal.pone.0094935398813124736609
- 14. Alsulaimani S et al. Elevated Homocysteine and Carotid Plaque Area and Densitometry in the Northern Manhattan Study (NOMAS).Stroke. 2013 Feb; 44(2): 457–461.10.1161/STROKEAHA.112.676155356791623287787
- 15. Selhub J et al. Association between plasma homo-cysteine concentrations and extracranial carotid–artery stenosis. N Engl J Med. 1995 Feb 2; 332(5): 286–91.10.1056/NEJM1995020233205027816063
- 16. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease–probable benefits of increasing folic acid in-takes. JAMA 1995; 274: 1049–1057.10.1001/jama.1995.035301300550287563456
- 17. Graham IM, Daly LE, Refsum HM, Robinson K, Brattström L, Ueland PM, et al. Plasma homo-cysteine as a risk factor for vascular disease–the European concerted action project. JAMA 1997; 277: 1775–178110.1001/jama.1997.035404600390309178790